Strategies for Delivery of siRNAs to Ovarian Cancer Cells

• Main Authors: Rossella Farra (Author), Matea Maruna (Author), Francesca Perrone (Author), Mario Grassi (Author), Fabio Benedetti (Author), Marianna Maddaloni (Author), Maguie El Boustani (Author), Salvo Parisi (Author), Flavio Rizzolio (Author), Giancarlo Forte (Author), Fabrizio Zanconati (Author), Maja Cemazar (Author), Urska Kamensek (Author), Barbara Dapas (Author), Gabriele Grassi (Author)
• Format: Book
• Published: MDPI AG, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The unmet need for novel therapeutic options for ovarian cancer (OC) deserves further investigation. Among the different novel drugs, small interfering RNAs (siRNAs) are particularly attractive because of their specificity of action and efficacy, as documented in many experimental setups. However, t...